Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03839641
Other study ID # PBRC 2018-029
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 14, 2019
Est. completion date December 31, 2020

Study information

Verified date August 2021
Source Pennington Biomedical Research Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The overarching aim of this study: To determine the effect of different meal compositions (high- vs. low-fat) on metabolic flexibility as it relates to meal-stimulated change in respiratory quotient (ΔRQ1) and sleep (ΔRQ2) metabolic flexibility, as well as the time course changes in respiratory quotient, RQ (i.e., peak RQ, time to peak RQ, nadir RQ, time to nadir, slope).


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date December 31, 2020
Est. primary completion date December 31, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - Eligibility criteria include: - Healthy male or female - Ages 18-40 y - BMI between 20 kg/m2 and 30 kg/m2 (±0.5 kg/m2 will be accepted) - Are willing to consume pre-prepared meals - Are willing to maintain current physical activity, sleep schedule, and dietary habits during the study. - Medically cleared for participation in the study by Medical Investigator Exclusion Criteria: - Participants are ineligible to participate (or will be excluded from participating in this study) if they meet any of the following criteria: - Unstable weight in the last 3 months [gain or loss >7 lb (or 3.2 kg)] - Currently working shift work - Smoking or use of tobacco products within the last 3 months - Amenorrhea (or absence of regular monthly cycles) - History of clinically diagnosed diabetes or a fasting blood glucose >126 mg/dL - Average screening blood pressure >140/90 mmHg - Previous bariatric surgery (or other surgeries) for obesity or weight loss - Use of medications affecting metabolism or sleep - History of neurological disease - History of cardiovascular disease (or other chronic diseases) - Pregnant, planning to become pregnant, or breastfeeding - Adherence to special restrained diets (e.g., low-carbohydrate, low-fat, or vegetarian/vegan diets) over the last 3 months.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
High fat meal
60% fat meal
Low fat meal
20% fat meal

Locations

Country Name City State
United States Pennington Biomedical Research Center Baton Rouge Louisiana

Sponsors (1)

Lead Sponsor Collaborator
Pennington Biomedical Research Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Overnight Respiratory Exchange Ratio 12-h mean of respiratory exchange ratio following each meal type.
measurement interval = 12h following start of meal (7pm)
The respiratory exchange ratio refers to the proportion of macronutrients being oxidized. A respiratory exchange ratio value of 1.0 indicates only carbohydrates are being oxidized, while a ratio value of 0.7 indicates only fats are being oxidized. Intermediate values, such as 0.85, indicates that both carbohydrate and fats are being oxidized.
12 hours
Secondary Sleep Respiratory Exchange Ratio mean of respiratory exchange ratio following each meal type during sleep period, 2am-5am., 2am-5am.
measurement interval = 3h (2am-5am)
The respiratory exchange ratio refers to the proportion of macronutrients being oxidized. A respiratory exchange ratio value of 1.0 indicates only carbohydrates are being oxidized, while a ratio value of 0.7 indicates only fats are being oxidized. Intermediate values, such as 0.85, indicates that both carbohydrate and fats are being oxidized.
3 h
Secondary Peak Increase in Respiratory Exchange Ratio mean of peak increase in respiratory exchange ratio (Peak values - baseline values) following each meal type
Peak values were defined as the peak respiratory exchange ratio value measured during the post-meal period, 6pm-10pm.
Baseline values were measured 1h prior to meal (5:00-5:45pm)
measurement interval of peak values= 4h (6pm-10pm)
A larger value in this measurement indicates that more carbohydrate than fats were being oxidized as fuel during the measurement period.
4 h
Secondary Peak Decrease in Respiratory Exchange Ratio mean of peak decrease in respiratory exchange ratio (baseline values -nadir values) following each meal type
Peak values were defined as the peak respiratory exchange ratio value measured during the post-meal period, 6pm-10pm.
Baseline values were measured 1h prior to meal (5:00-5:45pm)
measurement interval of nadir values= 12h (6pm-6am)
A larger value in this measurement indicates that more fats than carbohydrate were being oxidized as fuel during the measurement period.
12 h
Secondary Time to Peak Respiratory Exchange Ratio Average time from meal to peak respiratory exchange ratio value
This measurement indicates how long on average it took form the onset of the meal, 6pm, for the participants to achieve their highest/peak respiratory exchange ratio value.
12 h
Secondary Time to Nadir Respiratory Exchange Ratio Average time from meal to nadir respiratory exchange ratio value
This measurement indicates how long on average it took form the onset of the meal, 6pm, for the participants to achieve their lowest/nadir respiratory exchange ratio value.
12 h
Secondary Slope of Respiratory Exchange Ratio This value indicates the speed and magnitude of the participants change in respiratory exchange ratio between the peak and nadir values.
A more negative value in this measurement indicates either a short time interval between the highest and lowest respiratory exchange ratio values measured and/or a large difference between the highest and lowest values of respiratory exchange ratio values measured.
12 h
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2